BioRem Inc.
BIRMF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $31,191 | $35,756 | $41,702 | $48,289 |
| - Cash | $5,995 | $7,655 | $9,600 | $5,213 |
| + Debt | $3,085 | $3,140 | $3,370 | $3,557 |
| Enterprise Value | $28,280 | $31,241 | $35,472 | $46,633 |
| Revenue | $11,253 | $9,431 | $4,730 | $9,315 |
| % Growth | 19.3% | 99.4% | -49.2% | – |
| Gross Profit | $3,166 | $2,550 | $1,110 | $1,597 |
| % Margin | 28.1% | 27% | 23.5% | 17.1% |
| EBITDA | $1,746 | $1,163 | $229 | $427 |
| % Margin | 15.5% | 12.3% | 4.8% | 4.6% |
| Net Income | $831 | $745 | $37 | $171 |
| % Margin | 7.4% | 7.9% | 0.8% | 1.8% |
| EPS Diluted | 0.045 | 0.04 | 0.002 | -0.023 |
| % Growth | 11.5% | 1,900% | 108.5% | – |
| Operating Cash Flow | $901 | -$1,336 | $4,695 | -$1,690 |
| Capital Expenditures | $0 | -$249 | -$91 | -$5 |
| Free Cash Flow | $902 | -$1,585 | $4,604 | -$1,695 |